Gemcitabine nano-prodrug reprograms intratumoral metabolism and alleviates immunosuppression for hepatocellular carcinoma therapy

被引:10
作者
Wang, Yuehua [3 ,4 ]
Zhang, Bingchen [5 ]
Xi, Qiye [1 ,2 ]
Chen, Chaojie [3 ]
Wang, Zhenjie [1 ,2 ]
Li, Fangzhou [6 ]
Wang, Shengtao [1 ,2 ]
Yang, Wei [3 ]
Liang, Xing-Jie [6 ,7 ]
Yu, Zhiqiang [1 ,2 ,5 ]
Yu, Meng [1 ,2 ,8 ]
机构
[1] Southern Med Univ, Sch Pharmaceut Sci, NMPA Key Lab Res & Evaluat Drug Metab, Guangzhou 510515, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[3] Univ Shanghai Sci & Technol, Shidong Hosp, Base Achievement Transformat, Shanghai 200438, Peoples R China
[4] Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai 200093, Peoples R China
[5] Southern Med Univ, Affiliated Dongguan Hosp, Dongguan Inst Clin Canc Res, Dept Lab Med, Dongguan 523018, Peoples R China
[6] Natl Ctr Nanosci & Technol China, CAS Ctr Excellence Nanosci, CAS Key Lab Biomed Effects Nanomat & Nanosafety, 11 First North Rd, Beijing 100190, Peoples R China
[7] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[8] Southern Med Univ, Zhujiang Hosp, Guangzhou 510282, Peoples R China
基金
中国国家自然科学基金;
关键词
Gemcitabine; Glycolysis metabolism; Glutamine metabolism; Immunotherapy; Hepatocellular carcinoma; CANCER; TUMOR; TRANSPORT; CELLS;
D O I
10.1016/j.nantod.2023.102009
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
High-rate aerobic glycolysis and abnormal glutamine metabolism in tumor cells lead to their unlimited malignant proliferation and induce immune escape in the tumor microenvironment. In this study, the GLS1 inhibitor BPTES and the PDHC inhibitor CPI-613 were co-delivered by an ROS-sensitive GEM nano-prodrug (PD-G@BC), and a simultaneous inhibition of glycolysis and glutamine metabolism was achieved to deprive tumor cells of nutrient supply. In addition, this metabolism reprogramming effectively weakened the sources of glucose and glutamine in tumor cells, correspondingly thrived metabolism in antitumor immune cells, thereby increasing the intratumoral infiltration and functions of the immunogenic cells to alleviate the immunosuppressive responses. This multifunctional combination strategy will provide new insights into the design of synergistic cancer immunotherapy based on metabolic interventions.
引用
收藏
页数:16
相关论文
共 42 条
[1]   From Krebs to clinic: glutamine metabolism to cancer therapy [J].
Altman, Brian J. ;
Stine, Zachary E. ;
Dang, Chi V. .
NATURE REVIEWS CANCER, 2016, 16 (10) :619-634
[2]   Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer [J].
Bao, Macus Hao-Ran ;
Wong, Carmen Chak-Lui .
CELLS, 2021, 10 (07)
[3]   Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs [J].
Bhutia, Yangzom D. ;
Babu, Ellappan ;
Ramachandran, Sabarish ;
Ganapathy, Vadivel .
CANCER RESEARCH, 2015, 75 (09) :1782-1788
[4]   Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis [J].
Bonnay, Francois ;
Veloso, Ana ;
Steinmann, Victoria ;
Koecher, Thomas ;
Abdusselamoglu, Merve Deniz ;
Bajaj, Sunanjay ;
Rivelles, Elisa ;
Landskron, Lisa ;
Esterbauer, Harald ;
Zinzen, Robert P. ;
Knoblich, Juergen A. .
CELL, 2020, 182 (06) :1490-+
[5]   Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis [J].
Cai, Zhen ;
Li, Chien-Feng ;
Han, Fei ;
Liu, Chunfang ;
Zhang, Anmei ;
Hsu, Che-Chia ;
Peng, Danni ;
Zhang, Xian ;
Jin, Guoxiang ;
Rezaeian, Abdol-Hossein ;
Wang, Guihua ;
Zhang, Weina ;
Pan, Bo-Syong ;
Wang, Chi-Yun ;
Wang, Yu-Hui ;
Wu, Shih-Ying ;
Yang, Shun-Chin ;
Hsu, Fang-Chi ;
D'Agostino, Ralph B., Jr. ;
Furdui, Christina M. ;
Kucera, Gregory L. ;
Parks, John S. ;
Chilton, Floyd H. ;
Huang, Chih-Yang ;
Tsai, Fuu-Jen ;
Pasche, Boris ;
Watabe, Kounosuke ;
Lin, Hui-Kuan .
MOLECULAR CELL, 2020, 80 (02) :263-+
[6]   Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity [J].
Chen, Gui ;
Xu, Qing ;
Feng, Zhenzhen ;
Xu, Qinqin ;
Zhang, Xuhui ;
Yang, Yuanyuan ;
Zhang, Yuxuan ;
Liang, Xing-Jie ;
Yu, Zhiqiang ;
Yu, Meng .
ACS NANO, 2022, 16 (01) :951-962
[7]   Dual Tumor Microenvironment Remodeling by Glucose-Contained Radical Copolymer for MRI-Guided Photoimmunotherapy [J].
Cheng, Hongwei ;
Fan, Xiaoshan ;
Ye, Enyi ;
Chen, Hu ;
Yang, Jing ;
Ke, Lingjie ;
You, Mingliang ;
Liu, Minting ;
Zhang, Yong-Wei ;
Wu, Yun-Long ;
Liu, Gang ;
Loh, Xian Jun ;
Li, Zibiao .
ADVANCED MATERIALS, 2022, 34 (25)
[8]   A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma [J].
Choi, Jee-Eun ;
Sebastian, Carlos ;
Ferrer, Christina M. ;
Lewis, Caroline A. ;
Sade-Feldman, Moshe ;
LaSalle, Thomas ;
Gonye, Anna ;
Lopez, Begona G. C. ;
Abdelmoula, Walid M. ;
Regan, Michael S. ;
Cetinbas, Murat ;
Pascual, Gloria ;
Wojtkiewicz, Gregory R. ;
Silveira, Giorgia G. ;
Boon, Ruben ;
Ross, Kenneth N. ;
Tirosh, Itay ;
Saladi, Srinivas V. ;
Ellisen, Leif W. ;
Sadreyev, Ruslan I. ;
Benitah, Salvador Aznar ;
Agar, Nathalie Y. R. ;
Hacohen, Nir ;
Mostoslavsky, Raul .
NATURE METABOLISM, 2021, 3 (02) :182-+
[9]   Molecular basis of ligand recognition and transport by glucose transporters [J].
Deng, Dong ;
Sun, Pengcheng ;
Yan, Chuangye ;
Ke, Meng ;
Jiang, Xin ;
Xiong, Lei ;
Ren, Wenlin ;
Hirata, Kunio ;
Yamamoto, Masaki ;
Fan, Shilong ;
Yan, Nieng .
NATURE, 2015, 526 (7573) :391-+
[10]   CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling [J].
Gao Lixia ;
Xu Zhigang ;
Huang Zheng ;
Tang Yan ;
Yang Donglin ;
Huang Jiuhong ;
He Leilei ;
Liu Manran ;
Chen, Zhongzhu ;
Teng Yong .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)